Woofun AI reports that Canton Strategic Holdings finalized the divestiture of its biotech R&D unit, Gravitas Life Sciences, to Gravitas Collective Corp. The transaction received unanimous board approval and closed on July 17, 2026. The company stated it will now concentrate on the Canton Network ecosystem, transitioning into a digitalization service provider for financial markets with a focus on asset tokenization and compliant infrastructure.